ArticleDiagnostics (Basel, Switzerland)2022

Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.

Matteo Ferro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.